May 9, 2025- SMI® has appointed Lisa Hohman, CEO of Concordance as Board Chair; and Steve Mason, CEO, Global Medical Products and Distribution at Cardinal Health; and Amanda Chawla, Chief Supply Chain Officer and SVP for Stanford Medicine to its board of directors.
Hohman has been a member of SMI since 2010 and a board member since 2020. She said, “It is an honor to be board chair for an organization known for its commitment to the healthcare supply chain industry. I am committed to upholding SMI’s mission to make impactful and transformational change while serving the SMI community, alongside many of my peers and colleagues.”
Chawla shared her enthusiasm for joining the SMI Board, stating, “I’m honored to serve an organization as impactful as SMI. It plays a critical role in addressing today’s healthcare supply chain challenges while paving the way for future innovation. From tackling complex issues like resiliency to embracing emerging technologies such as AI, SMI is driving meaningful progress across the industry that I am excited to be part of.”
Since its inception in 2004, the SMI Board of Directors sets the strategy for SMI and the work of its members. The Board includes twelve members, 6 provider partners and 6 industry partners to ensure a balanced representation of its membership which consists of leaders from large integrated delivery networks (IDNs) as well as suppliers, manufacturers, distributors, technology, and service organizations.
To learn more about SMI, its Board of Directors, and its community of members, visit: www.smisupplychain.com